BioCentury
ARTICLE | Financial News

Harpoon slips after pricing $75.6M IPO

February 8, 2019 4:00 AM UTC

Harpoon Therapeutics Inc. (NASDAQ:HARP) shares lost $0.50 to $13.50 in their first day of trading Friday after the company raised $75.6 million in an IPO that priced at the midpoint of its proposed range.

Harpoon sold 5.4 million shares at $14, within the $13-$15 range. The price gave Harpoon a valuation of $334.7 million. Underwriters are Citigroup, SVB Leerink, Canaccord and Wedbush PacGrow...

BCIQ Company Profiles

Harpoon Therapeutics Inc.